Key facts
- This page summarizes Jonathan P. DiVincenzo's Form 4 filing for LABORATORY CORP OF AMERICA HOLDINGS (LH).
- 8 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2024, 15:25.
Jonathan P. DiVincenzo - 06 Feb 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)
- Reporting relationship
- EVP, Pres, Central Labs & Intl
- Issuer ticker
- LH
- Reported as of
- 06 Feb 2024
- Net transaction value
- -$26,621
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2024, 15:25:25 UTC
- Prior SEC filing
- 06 Feb 2024
- Next SEC filing
- 13 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra D. van der Vaart, Attorney-in-Fact for Jonathan P. DiVincenzo
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jonathan P. DiVincenzo filed Form 4 for LABORATORY CORP OF AMERICA HOLDINGS (LH) on 08 Feb 2024.
Change
- Previous filing in this sequence was filed on 06 Feb 2024.
- Current net transaction value: -$26,621.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +224
- Change %
- +6.4%
- Price
- Shares after
- 3,740
- Date
- 07 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
LH
transaction
Common Stock
Tax liability
- Transaction value
- $17,449
- Shares
- -78
- Change %
- -2.1%
- Price
- $223.71
- Shares after
- 3,662
- Date
- 07 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
LH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +138
- Change %
- +3.8%
- Price
- Shares after
- 3,800
- Date
- 07 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
LH
transaction
Common Stock
Tax liability
- Transaction value
- $9,172
- Shares
- -41
- Change %
- -1.1%
- Price
- $223.71
- Shares after
- 3,759
- Date
- 07 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LH
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +980
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 5,540
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 980
- Exercise price
- Footnotes
- F1, F3, F4
LH
transaction
Derivative
Non-qualified Stock Options
Award
- Transaction value
- $0
- Shares
- +3,000
- Change %
- Price
- $0.000000
- Shares after
- 3,000
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- $222.28
- Footnotes
- F5, F6
LH
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -224
- Change %
- -4%
- Price
- $0.000000
- Shares after
- 5,316
- Date
- 07 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 224
- Exercise price
- Footnotes
- F1, F4, F7
LH
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -138
- Change %
- -2.6%
- Price
- $0.000000
- Shares after
- 5,178
- Date
- 07 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 138
- Exercise price
- Footnotes
- F1, F4, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
Footnote F2
Stock withholding to satisfy tax withholding obligations.
Footnote F3
The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025.
Footnote F4
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Footnote F5
Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
Footnote F6
The option vests in three equal annual installments beginning on the date reflected in this column.
Footnote F7
The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.